Stoke Therapeutics Inc (STOK)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current STOK market cap is 655.71M. The company's latest EPS is USD -1.6298 and P/E is -7.37.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.22M | 4.83M | 4.89M | 22.61M | 158.57M |
| Operating Income | -28.37M | -29.34M | -30.01M | -13.65M | 111.24M |
| Net Income | -26.37M | -25.7M | -26.43M | -10.48M | 112.88M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 12.41M | 8.78M | 36.56M |
| Operating Income | -53.04M | -86.07M | -104.36M | -114.77M | -101.37M |
| Net Income | -52.24M | -85.81M | -101.07M | -104.7M | -88.98M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 205.18M | 307.76M | 293.32M | 271.56M | 406.89M |
| Total Liabilities | 64.84M | 65.05M | 61.21M | 42.53M | 56.81M |
| Total Equity | 140.34M | 242.71M | 232.11M | 229.02M | 350.07M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 297.93M | 238.87M | 256.07M | 228.34M | 271.56M |
| Total Liabilities | 11.85M | 21.09M | 71.22M | 68.78M | 42.53M |
| Total Equity | 286.08M | 217.78M | 184.85M | 159.57M | 229.02M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.57M | -42.04M | -63.66M | -86.85M | 131.83M |
| Investing | 9.99M | -78.29M | -108.29M | -107.48M | 13.63M |
| Financing | 1.72M | 122.37M | 130.53M | 131.09M | 1.37M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.22M | -66.91M | -31.87M | -81.07M | -86.85M |
| Investing | -1.05M | -76.43M | -45.88M | 105.95M | -107.48M |
| Financing | 108.11M | 1.28M | 46.41M | 53.01M | 131.09M |
| Market Cap | 655.71M |
| Price to Earnings Ratio | -7.37 |
| Price to Sales Ratio | 17.94 |
| Price to Cash Ratio | 5.12 |
| Price to Book Ratio | 2.86 |
| Dividend Yield | - |
| Shares Outstanding | 54.6M |
| Average Volume (1 week) | 395.51k |
| Average Volume (1 Month) | 546.49k |
| 52 Week Change | -10.04% |
| 52 Week High | 16.15 |
| 52 Week Low | 5.35 |
| Spread (Intraday) | 0.81 (6.55%) |
| Company Name | Stoke Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.stoketherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
